B7-H3 promotes the migration and invasion of colorectal cancer cells via regulating the actin cytoskeleton and RhoA/ROCK1/LIMK1 signaling pathway

Author:

Zhao Anjing1,Zhu Xingchao1,Wu Hongya1,Wang Jiayu1,Zhang Mengting1,Xiang Jingrong1,Xia Suhua1,shi Tongguo1,Xi Qinhua1

Affiliation:

1. First Affiliated Hospital of Soochow University

Abstract

Abstract Aberrant expression of B7 homolog 3 protein (B7-H3) has been detected in various cancers including colorectal cancer (CRC) and implicated in modulating multiple biological functions of CRC cells. However, its role in CRC metastasis has not yet been determined. In this study, we demonstrated that B7-H3 was highly expressed in CRC tissues and positively associated with poor prognosis of CRC patients. B7-H3 knockdown significantly inhibited the migration and invasion of CRC cells. B7-H3 overexpression had the opposite effect. Moreover, we determined that B7-H3 could regulate actin cytoskeleton and the RhoA/ROCK1/LIMK1 pathway. Importantly, the BDP5290, an inhibitor of the RhoA/ROCK1/LIMK1 axis, reversed the effects of B7-H3 overexpression on actin filament accumulating, migration, and invasion of CRC cells. In sum, our study concluded that B7-H3 facilitated CRC cell actin filament accumulating, migration, and invasion through the RhoA/ROCK1/LIMK1 axis.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Mining Google Trends data for nowcasting and forecasting colorectal cancer (CRC) prevalence;Tudor C;PeerJ Comput Sci,2023

2. Colorectal cancer surgery: is further research necessary? Anaesthesia;Bailey CR,2022

3. SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer;Weng S;Front Immunol,2022

4. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond;Al Bitar S;World J Gastroenterol,2023

5. B7-H3 in Cancer - Beyond Immune Regulation;Flem-Karlsen K;Trends Cancer,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3